Find a Trial

Trial Summary


Protocol No.NEUR-SPRINGWORKS-MEK-NF-201
StatusOPEN TO ACCRUAL
Principal InvestigatorNevel, Kathryn
ScopeNational
PhasePhase II
Age GroupAdults and Children
TitleA Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients with Neurofibromatosis Type 1 (NF1)-Associated Inoperable Plexiform Neurofibromas (PNs) that are Causing Significant Morbidity
Applicable Disease SitesBrain and Nervous System
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactJill Mazurczyk, Phone: +1 317-418-1060
    Pager:
    Email: jmazurcz@iu.edu